201 related articles for article (PubMed ID: 15740733)
1. Endotoxin from various gram-negative bacteria has differential effects on function of hepatic cytochrome P450 and drug transporters.
Ueyama J; Nadai M; Kanazawa H; Iwase M; Nakayama H; Hashimoto K; Yokoi T; Baba K; Takagi K; Takagi K; Hasegawa T
Eur J Pharmacol; 2005 Mar; 510(1-2):127-34. PubMed ID: 15740733
[TBL] [Abstract][Full Text] [Related]
2. Effect of pioglitazone on endotoxin-induced decreases in hepatic drug-metabolizing enzyme activity and expression of CYP3A2 and CYP2C11.
Ueyama J; Kitaichi K; Nadai M; Iwase M; Tomyo N; Kanazawa H; Suzuki R; Takagi K; Takagi K; Hasegawa T
Eur J Pharmacol; 2004 Sep; 498(1-3):257-65. PubMed ID: 15364003
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of cytochrome P450 proteins and its activities by Shiga-like toxin II from Escherichia coli O157:H7.
Kitaichi K; Nakayama H; Ueyama J; Nadai M; Baba K; Takagi K; Takagi K; Ohta M; Hasegawa T
Biochem Pharmacol; 2004 Apr; 67(8):1427-35. PubMed ID: 15041460
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent effects of Klebsiella pneumoniae endotoxin on hepatic drug-metabolizing enzyme activity in rats.
Nadai M; Sekido T; Matsuda I; Li W; Kitaichi K; Itoh A; Nabeshima T; Hasegawa T
J Pharm Pharmacol; 1998 Aug; 50(8):871-9. PubMed ID: 9751451
[TBL] [Abstract][Full Text] [Related]
5. Effect of thalidomide on endotoxin-induced decreases in activity and expression of hepatic cytochrome P450 3A2.
Ueyama J; Nadai M; Zhao YL; Kanazawa H; Takagi K; Kondo T; Takagi K; Wakusawa S; Abe F; Saito H; Miyamoto K; Hasegawa T
Biol Pharm Bull; 2008 Aug; 31(8):1596-600. PubMed ID: 18670095
[TBL] [Abstract][Full Text] [Related]
6. Changes of midazolam pharmacokinetics in Wistar rats treated with lipopolysaccharide: relationship between total CYP and CYP3A2.
Kato R; Yamashita S; Moriguchi J; Nakagawa M; Tsukura Y; Uchida K; Amano F; Hirotani Y; Ijiri Y; Tanaka K
Innate Immun; 2008 Oct; 14(5):291-7. PubMed ID: 18809653
[TBL] [Abstract][Full Text] [Related]
7. Differential Effects of Sunitinib on the Expression Profiles of Xenobiotic-Metabolizing Enzymes and Transporters in Rat Liver and Kidneys.
Korashy HM; Ansari MA; Maayah ZH; Imam F; Raish M; Attafi IM; Alharbi NO; Moraished BA
Basic Clin Pharmacol Toxicol; 2016 Aug; 119(2):173-83. PubMed ID: 26797788
[TBL] [Abstract][Full Text] [Related]
8. Decreased antipyrine clearance following endotoxin administration: in vivo evidence of the role of nitric oxide.
Kitaichi K; Wang L; Takagi K; Iwase M; Shibata E; Nadai M; Hasegawa T
Antimicrob Agents Chemother; 1999 Nov; 43(11):2697-701. PubMed ID: 10543749
[TBL] [Abstract][Full Text] [Related]
9. Role of tumor necrosis factor-alpha in down-regulation of hepatic cytochrome P450 and P-glycoprotein by endotoxin.
Miyoshi M; Nadai M; Nitta A; Ueyama J; Shimizu A; Takagi K; Nabeshima T; Takagi K; Saito K; Hasegawa T
Eur J Pharmacol; 2005 Jan; 507(1-3):229-37. PubMed ID: 15659313
[TBL] [Abstract][Full Text] [Related]
10. Recovery of hepatic function determined by cytochrome P450-dependent drug metabolism lags after compensatory hepatic volume changes after portal vein ligation in rats.
Takemura S; Minamiyama Y; Hirohashi K; Kubo S; Funae Y; Kinoshita H
J Surg Res; 2006 Aug; 134(2):285-91. PubMed ID: 16564546
[TBL] [Abstract][Full Text] [Related]
11. Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats.
Ando H; Nishio Y; Ito K; Nakao A; Wang L; Zhao YL; Kitaichi K; Takagi K; Hasegawa T
Antimicrob Agents Chemother; 2001 Dec; 45(12):3462-7. PubMed ID: 11709325
[TBL] [Abstract][Full Text] [Related]
12. Effects of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats.
Chen J; Robertson G; Field J; Liddle C; Farrell GC
Hepatology; 1998 Sep; 28(3):624-30. PubMed ID: 9731550
[TBL] [Abstract][Full Text] [Related]
13. Effect of sodium alterations on hepatic cytochrome P450 3A2 and 2C11 and renal function in rats.
Liu J; Callahan SM; Brunner LJ
Drug Dev Ind Pharm; 2003 Aug; 29(7):767-75. PubMed ID: 12906334
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis for the impact of hypercholesterolemia on expressions of hepatic drug transporters and metabolizing enzymes.
Liu Y; Pu QH; Wu MJ; Yu C
Xenobiotica; 2016 Oct; 46(10):940-7. PubMed ID: 26887802
[TBL] [Abstract][Full Text] [Related]
15. Molecular and macromolecular alterations of recombinant adenoviral vectors do not resolve changes in hepatic drug metabolism during infection.
Callahan SM; Wonganan P; Croyle MA
Virol J; 2008 Sep; 5():111. PubMed ID: 18826641
[TBL] [Abstract][Full Text] [Related]
16. Effects of bacterial lipopolysaccharide on the pharmacokinetics of metformin in rats.
Choi YH; Lee I; Lee MG
Int J Pharm; 2007 Jun; 337(1-2):194-201. PubMed ID: 17275228
[TBL] [Abstract][Full Text] [Related]
17. Decrease in hepatic CYP2C11 mRNA and increase in heme oxygenase activity after intracerebroventricular injection of bacterial endotoxin.
Shimamoto Y; Tasaki T; Kitamura H; Hirose K; Kazusaka A; Fujita S
J Vet Med Sci; 1999 Jun; 61(6):609-13. PubMed ID: 10423681
[TBL] [Abstract][Full Text] [Related]
18. Impact of transgene expression on drug metabolism following systemic adenoviral vector administration.
Callahan SM; Boquet MP; Ming X; Brunner LJ; Croyle MA
J Gene Med; 2006 May; 8(5):566-76. PubMed ID: 16508909
[TBL] [Abstract][Full Text] [Related]
19. Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats.
Kalitsky-Szirtes J; Shayeganpour A; Brocks DR; Piquette-Miller M
Drug Metab Dispos; 2004 Jan; 32(1):20-7. PubMed ID: 14709616
[TBL] [Abstract][Full Text] [Related]
20. Altered cytochrome P450 and P-glycoprotein levels in rats during simulated weightlessness.
Lu SK; Bai S; Javeri K; Brunner LJ
Aviat Space Environ Med; 2002 Feb; 73(2):112-8. PubMed ID: 11846179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
